Bangalore, Karnataka -- (SBWIRE) -- 12/27/2016 -- The market value for intrathecal pump will undergo steady growth over the projected period driven by greater patient awareness and technological advancement. Single digit growth in units sold will occur as patient awareness of the benefits of these devices is increasing. There is a high level of patient satisfaction with these devices which leads to high replacement rates and the lower satisfaction rates with neurostimulators drives growth in pumps as well. The market for intrathecal pumps is impacted by trends in the neurostimulation market.

Due to the higher reimbursement for neurostimulation, the market for intrathecal pumps did not witness significant growth prior to 2014 when the reimbursement for neurostimulation trials was reduced. As a result of this change, the market saw an increase in growth after these changes. However, competing neurostimulation is still eroding some of the pain pump market since neurostimulation tends to be the initial line of treatment for chronic back pain.

Spanning over 68 pages "US Market Report for Intrathecal Pumps 2017 - MedCore" report covers Executive Summary, Competitive Analysis, Research Methodology, Disease Overview, Product Assessment, Intrathecal Pump Market. The report covered companies are - Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed, Mizuho America, RauMedic

For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-intrathecal-pumps-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.